Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Dynavax Technologies Q3 EPS $0.10, Sales $69.51M Beat $60.30M Estimate

Author: Benzinga Newsdesk | November 02, 2023 05:33pm
Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.01) by 1100 percent. This is a 76.74 percent decrease over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $69.51 million which beat the analyst consensus estimate of $60.30 million by 15.28 percent. This is a 58.56 percent decrease over sales of $167.74 million the same period last year.

Posted In: DVAX